Cardiovascular Risk Factor, Cardiovascular Diseases
Conditions
Keywords
cardiovascular disease, motor activity, woman, workplace, Delivery of health care
Brief summary
The purpose of this prospective randomized controlled trial is to explore the role of a motion sensor with accompany web application on step counts, energy balance, and metabolic markers in nurses. Additionally, eating behaviours, behavioural regulation in exercise, and mood states that may impact these parameters will also be examined.
Interventions
BEHAVIORALMotion sensor
To explore the role of a motion sensor with accompanying web application on step counts, energy balance, and metabolic markers in nurses
Sponsors
Ottawa Heart Institute Research Corporation
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes
Inclusion criteria
* 1\. Participant must be a registered nurse with the University of Ottawa Heart Institute; 2\. Participant must be 18 years of age or older; 3\. Participant must be able to walk unassisted; 4\. Participant is able and willing to provide informed consent.
Exclusion criteria
1. Participant is pregnant, lactating or planning to become pregnant during the study period; 2. Participant is unable to read and understand English; 3. Medical contraindications to exercise; 4. Already using a motion sensor device to track physical activity. -
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Step counts | 6 weeks during observation and 6 weeks during intervention | All participants will be asked to wear a Tractivity® motion sensor device on their ankle for to assess their daily step count and physical activity energy expenditure |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Body Mass (kg) | Screening (week 1), Observation (weeks 2-5), during the intervention (weeks 6-9), post study at week 26 and week 52 | Body weight will be measured using a digital scale to the nearest 0.1 kilogram |
| Waist Circumference | Screening (week 1), Observation (weeks 2-5), during the intervention (weeks 6-9), post study at week 26 and week 52 | Waist circumference will be measured using a tape measure |
| Fat mass | Screening (week 1), Observation (weeks 2-5), during the intervention (weeks 6-9), post study at week 26 and week 52 | Fat mass will be measured using bioelectrical impedance analysis |
Countries
Canada
Outcome results
None listed